| p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion A Helman, A Klochendler, N Azazmeh, Y Gabai, E Horwitz, S Anzi, ... Nature medicine 22 (4), 412-420, 2016 | 309 | 2016 |
| Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity Y Schlesinger, O Yosefov-Levi, D Kolodkin-Gal, RZ Granit, L Peters, ... Nature communications 11 (1), 4516, 2020 | 130 | 2020 |
| Control of breast cancer growth and initiation by the Stem cell–associated transcription factor TCF3 M Slyper, A Shahar, A Bar-Ziv, RZ Granit, T Hamburger, B Maly, T Peretz, ... Cancer research 72 (21), 5613-5624, 2012 | 87 | 2012 |
| Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling CR Pradeep, WJ Köstler, M Lauriola, RZ Granit, F Zhang, J Jacob-Hirsch, ... Oncogene 31 (7), 907-917, 2012 | 61 | 2012 |
| RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer O Tarcic, RZ Granit, IS Pateras, H Masury, B Maly, Y Zwang, Y Yarden, ... Cell Death & Differentiation 24 (4), 694-704, 2017 | 55 | 2017 |
| EZH2 promotes a bi-lineage identity in basal-like breast cancer cells RZ Granit, Y Gabai, T Hadar, Y Karamansha, L Liberman, I Waldhorn, ... Oncogene 32 (33), 3886-3895, 2013 | 49 | 2013 |
| Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer RZ Granit, H Masury, R Condiotti, Y Fixler, Y Gabai, T Glikman, S Dalin, ... Cell reports 24 (12), 3237-3250, 2018 | 43 | 2018 |
| Axes of differentiation in breast cancer: untangling stemness, lineage identity, and the epithelial to mesenchymal transition RZ Granit, M Slyper, I Ben‐Porath Wiley Interdisciplinary Reviews: Systems Biology and Medicine 6 (1), 93-106, 2014 | 26 | 2014 |
| Mucinous histology, BRCA1/2 mutations, and elevated tumor mutational burden in colorectal cancer N Harpaz, YE Gatt, RZ Granit, H Fruchtman, A Hubert, A Grinshpun Journal of Oncology 2020, 2020 | 15 | 2020 |
| Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers A Grinshpun, N Halpern, RZ Granit, A Hubert, T Hamburger, Y Laitman, ... European Journal of Human Genetics 26 (3), 382-386, 2018 | 12 | 2018 |
| STAT3 activation in HER2‐positive breast cancers: Analysis of data from a large prospective trial A Sonnenblick, D Agbor‐tarh, E de Azambuja, S Hultsch, M Izquierdo, ... International journal of cancer 148 (6), 1529-1535, 2021 | 11 | 2021 |
| Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapy A Grinshpun, N Gavert, RZ Granit, H Masuri, I Ben-Porath, S Breuer, ... Cancer Biology & Therapy 19 (8), 645-648, 2018 | 9 | 2018 |
| A universal cell‐free DNA approach for response prediction to preoperative chemoradiation in rectal cancer A Grinshpun, A Kustanovich, D Neiman, R Lehmann‐Werman, A Zick, ... International Journal of Cancer 152 (7), 1444-1451, 2023 | 3 | 2023 |
| High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing LA Cohen-Aharonov, A Rebibo-Sabbah, A Yaacov, RZ Granit, M Strauss, ... Plos one 17 (6), e0253404, 2022 | 3 | 2022 |
| Gene model correction for PVRIG in single cell and bulk sequencing data enables accurate detection and study of its functional relevance S Nemzer, N Sabath, A Wool, Z Alteber, H Ando, A Nickles-Fader, ... bioRxiv, 2022.11. 02.514879, 2022 | 1 | 2022 |
| Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor Effects A Menachem, Z Alteber, G Cojocaru, T Fridman Kfir, D Blat, O Leiderman, ... Cancer Immunology Research, OF1-OF17, 2024 | | 2024 |
| Pvrl2 and/or pvrig as biomarkers for treatment RZ Granit, GS Cojocaru, E Ophir, A Novik, N Sabath, Z Alteber US Patent App. 18/185,632, 2024 | | 2024 |
| Unleashing natural IL-18 activity using an anti-IL-18BP blocker antibody induces potent immune stimulation and anti-tumor effects A Menachem, Z Alteber, G Cojocaru, TF Kfir, D Blat, O Leiderman, ... Cancer Research 84 (6_Supplement), 4072-4072, 2024 | | 2024 |
| PVRIG is uniquely expressed in tumor dendritic cells-rich niches on stem-like memory T cells and its blockade may induce immune infiltration and activation in non-inflamed tumors Z Alteber, G Cojocaru, RZ Granit, I Barbiro, A Wool, M Frenkel, A Novik, ... Cancer Research 84 (6_Supplement), 7533-7533, 2024 | | 2024 |
| 550 Harnessing natural IL-18 activity through IL-18BP blockade reshapes the tumor microenvironment for potent anti-tumor immune response A Menachem, Z Alteber, G Cojocaru, TF Kfir, D Blat, O Leiderman, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
Yuval DorProfessor of Biology, Hebrew University of JerusalemVerified email at ekmd.huji.ac.il
